NCAM1 and neoplasm: A total of 372 patients were divided into two subgroups stratified by the median density of each subset, i.e., CD3+, CD4+, CD8+, CD45RO+, and CD56+ immune cells, in tumor stroma into higher half (n = 186) and lower half (n = 186).